A ureido-sulfonamide inhibitor of carbonic anhydrases IX and CAXII (Kis = 45.1 and 4.5 nM, respectively) that binds only under hypoxic conditions, reducing extracellular acidity and resulting in significant inhibition of tumor growth and metastasis in experimental models.